• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Spectrum and Carrier Frequencies of Common Pathogenic Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Men from the General Population: The Role of Ethnicity.普通人群男性中常见致病性囊性纤维化跨膜传导调节因子基因突变的谱系及携带频率:种族的作用
Int J Mol Sci. 2025 Jul 10;26(14):6625. doi: 10.3390/ijms26146625.
2
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.囊性纤维化的增效剂(针对III类和IV类突变的特定疗法)。
Cochrane Database Syst Rev. 2015 Mar 26(3):CD009841. doi: 10.1002/14651858.CD009841.pub2.
3
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).针对携带 II 类 CFTR 基因突变(最常见的是 F508del)的囊性纤维化患者的校正治疗(有或没有增效剂)。
Cochrane Database Syst Rev. 2023 Nov 20;11(11):CD010966. doi: 10.1002/14651858.CD010966.pub4.
4
CFTR mutations in men with congenital bilateral absence of the vas deferens (CBAVD): a systemic review and meta-analysis.CFTR 基因突变与先天性双侧输精管缺如症(CBAVD)男性:系统评价和荟萃分析。
Hum Reprod. 2012 Jan;27(1):25-35. doi: 10.1093/humrep/der377. Epub 2011 Nov 10.
5
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.用于囊性纤维化相关肺部疾病的局部囊性纤维化跨膜传导调节因子基因替代疗法。
Cochrane Database Syst Rev. 2016 Jun 17;2016(6):CD005599. doi: 10.1002/14651858.CD005599.pub5.
6
Evaluation of elexacaftor-tezacaftor-ivacaftor treatment in individuals with cystic fibrosis and CFTR in the USA: a prospective, multicentre, open-label, single-arm trial.在美国对患有囊性纤维化和CFTR的个体进行的依列卡福托-替扎卡福托-依伐卡托治疗评估:一项前瞻性、多中心、开放标签、单臂试验。
Lancet Respir Med. 2024 Dec;12(12):947-957. doi: 10.1016/S2213-2600(24)00205-4. Epub 2024 Aug 26.
7
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.12岁及以上囊性纤维化患者使用万扎卡托-替扎卡托-地替瓦卡托与依列卡托-替扎卡托-艾伐卡托的对比研究(SKYLINE试验VX20 - 121 - 102和VX20 - 121 - 103):两项随机、活性对照3期试验的结果
Lancet Respir Med. 2025 Mar;13(3):256-271. doi: 10.1016/S2213-2600(24)00411-9. Epub 2025 Jan 2.
8
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.依伐卡托(Ataluren)及类似化合物(针对 I 类提前终止密码子突变的特异性治疗药物)治疗囊性纤维化。
Cochrane Database Syst Rev. 2023 Mar 3;3(3):CD012040. doi: 10.1002/14651858.CD012040.pub3.
9
Risk of Pancreatic Cancer in Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Germline Variants: A Retrospective Cohort Study.囊性纤维化及囊性纤维化跨膜传导调节因子种系变异与胰腺癌风险:一项回顾性队列研究
Clin Transl Gastroenterol. 2025 May 27. doi: 10.14309/ctg.0000000000000857.
10
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity.囊性纤维化跨膜电导调节因子可能影响 SARS-CoV-2 感染和 COVID-19 疾病严重程度的机制。
FASEB J. 2023 Nov;37(11):e23220. doi: 10.1096/fj.202300077R.

本文引用的文献

1
Population Characteristics of the Spectrum and Frequencies of Gene Mutations in Patients with Cystic Fibrosis from the Republic of Bashkortostan (Russia).俄罗斯巴什科尔托斯坦共和国囊性纤维化患者基因突变谱及频率的人口特征。
Genes (Basel). 2024 Oct 17;15(10):1335. doi: 10.3390/genes15101335.
2
Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the Gene.在 基因中存在复杂等位基因 [L467F;F508del] 的情况下,估算氯离子通道残留功能并评估靶向药物的效率。
Int J Mol Sci. 2024 Sep 27;25(19):10424. doi: 10.3390/ijms251910424.
3
Molecular analysis of gene mutations among Iraqi cystic fibrosis patients.伊拉克囊性纤维化患者基因突变的分子分析
Egypt J Med Hum Genet. 2021;22(1):45. doi: 10.1186/s43042-021-00164-x. Epub 2021 May 11.
4
Diversity of CFTR variants across ancestries characterized using 454,727 UK biobank whole exome sequences.使用 454,727 份英国生物银行全外显子组序列对跨种族的 CFTR 变体多样性进行特征描述。
Genome Med. 2024 Mar 21;16(1):43. doi: 10.1186/s13073-024-01316-5.
5
Pathogenic Variants and Genotypes of the Gene in Russian Men with Cystic Fibrosis and CBAVD Syndrome.俄罗斯囊性纤维化和先天性输精管发育不全综合征男性中 基因的致病变体和基因型。
Int J Mol Sci. 2023 Nov 14;24(22):16287. doi: 10.3390/ijms242216287.
6
Sexual and Reproductive Health Among Men With Cystic Fibrosis.男性囊性纤维化患者的性与生殖健康
Urology. 2023 Sep;179:9-15. doi: 10.1016/j.urology.2023.06.017. Epub 2023 Jun 26.
7
The Gene Germline Heterozygous Pathogenic Variants in Russian Patients with Malignant Neoplasms and Healthy Carriers: 11,800 WGS Results.俄罗斯恶性肿瘤患者及健康携带者中胚系杂合致病性变异基因:11800 例 WGS 结果。
Int J Mol Sci. 2023 Apr 27;24(9):7940. doi: 10.3390/ijms24097940.
8
Identification of risk genes in Chinese nonobstructive azoospermia patients based on whole-exome sequencing.基于全外显子测序的中国非梗阻性无精子症患者风险基因的鉴定。
Asian J Androl. 2023 Jan-Feb;25(1):66-72. doi: 10.4103/aja202275.
9
Androgen Receptor Gene CAG Repeat Length Varies and Affects Semen Quality in an Ethnic-Specific Fashion in Young Men from Russia.雄激素受体基因 CAG 重复长度存在差异,并以特定种族的方式影响俄罗斯年轻男性的精液质量。
Int J Mol Sci. 2022 Sep 13;23(18):10594. doi: 10.3390/ijms231810594.
10
Heterogeneous spectrum of CFTR gene mutations in Chinese patients with CAVD and the dilemma of genetic blocking strategy.中国 CAVD 患者 CFTR 基因突变的异质性谱及基因阻断策略的困境。
Reproduction. 2022 Jul 14;164(3):R47-R56. doi: 10.1530/REP-21-0315. Print 2022 Sep 1.

普通人群男性中常见致病性囊性纤维化跨膜传导调节因子基因突变的谱系及携带频率:种族的作用

The Spectrum and Carrier Frequencies of Common Pathogenic Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations in Men from the General Population: The Role of Ethnicity.

作者信息

Osadchuk Ludmila, Ivanov Mikhail, Komova Elena, Osadchuk Alexander

机构信息

Department of Human Molecular Genetics, Federal Research Center 'Institute of Cytology and Genetics', The Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Joint Stock Company Vector Best, Novosibirsk District, 630117 Novosibirsk, Russia.

出版信息

Int J Mol Sci. 2025 Jul 10;26(14):6625. doi: 10.3390/ijms26146625.

DOI:10.3390/ijms26146625
PMID:40724872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12294213/
Abstract

Mutations in the CFTR gene, which cause the autosomal recessive disease cystic fibrosis, can also affect male fertility. The aim of this study was to investigate the spectrum and carrier frequency of common pathogenic CFTR variants among men from the general population, analyze ethnic differences, and assess associations with male fertility indicators. Male volunteers ( = 1895) from six cities in Russia and Belarus were analyzed for the carrier frequencies of 17 pathogenic CFTR variants and two polymorphisms, as well as semen quality and reproductive hormone levels. Heterozygous carriers of six pathogenic CFTR mutations, F508del, G542X, N1303K, 3849+10kbC>T, CFTRdele2,3, and R117C, and two polymorphisms, IVS9-5T and 5T-(12-13) TG, were identified, with cumulative frequencies of 2.06% and 6.65%, respectively. Significant ethnic differences were revealed in the spectrum and carrier frequencies of pathogenic CFTR variants among Slavs, Buryats, and Yakuts. Slavs exhibited a high proportion of heterozygous carriers of CFTR mutations (2.70%), whereas none were detected among Buryats and Yakuts. The highest carrier frequency for the CFTR polymorphism was observed among Slavs (8.35%), followed by Buryats (5.83%) and Yakuts (1.36%). No association was found between the carriers of identified CFTR variants and male fertility indicators. Thus, the spectrum and carrier frequency of genetic CFTR variants are determined by the ethnic composition of the population, providing a basis for ethnicity-specific screening of pathogenic CFTR variants.

摘要

导致常染色体隐性疾病囊性纤维化的CFTR基因突变,也会影响男性生育能力。本研究的目的是调查普通人群男性中常见致病性CFTR变异的谱系和携带频率,分析种族差异,并评估其与男性生育指标的关联。对来自俄罗斯和白俄罗斯六个城市的1895名男性志愿者进行了分析,检测了17种致病性CFTR变异和两种多态性的携带频率,以及精液质量和生殖激素水平。鉴定出六种致病性CFTR突变(F508del、G542X、N1303K、3849+10kbC>T、CFTRdele2,3和R117C)和两种多态性(IVS9-5T和5T-(12-13)TG)的杂合携带者,其累积频率分别为2.06%和6.65%。在斯拉夫人、布里亚特人和雅库特人之间,致病性CFTR变异的谱系和携带频率存在显著的种族差异。斯拉夫人中CFTR突变杂合携带者的比例较高(2.70%),而在布里亚特人和雅库特人中未检测到。CFTR多态性的最高携带频率在斯拉夫人中观察到(8.35%),其次是布里亚特人(5.83%)和雅库特人(1.36%)。在已鉴定的CFTR变异携带者与男性生育指标之间未发现关联。因此,遗传CFTR变异的谱系和携带频率由人群的种族构成决定,为致病性CFTR变异的种族特异性筛查提供了依据。